Oncology

  1. Polivy (polatuzumab vedotin-piiq)
    Polivy (polatuzumab vedotin-piiq)
    by Genentech, Inc
    for Lymphoma
    €0.00
  2. Nubeqa (darolutamide)
    Nubeqa (darolutamide)
    by Bayer HealthCare Pharmaceuticals Inc.
    for Prostate Cancer
    €0.00
  3. Tibsovo (ivosidenib)
    Tibsovo (ivosidenib)
    by Agios Pharmaceuticals, Inc.
    for Leukemia
    €33,468.00
  4. Piqray (alpelisib)
    Piqray (alpelisib)
    by Novartis
    for Breast Cancer
    €22,537.00
  5. Rozlytrek (entrectinib)
    Rozlytrek (entrectinib)
    by Genentech, Inc
    for Solid Tumor
    €10,214.98
  6. Balversa (erdafitinib)
    Balversa (erdafitinib)
    by Janssen Pharmaceutica
    for Urothelial Carcinoma
    €75,340.00
  7. Calquence (acalabrutinib)
    Calquence (acalabrutinib)
    by AstraZeneca Pharmaceuticals LP
    for Lymphoma
    €20,427.96
  8. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by Sanofi
    for Skin Cancer
    €3,147.60
  9. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €10,885.55
View as Grid List

Items 1-9 of 48

Page
per page
Set Descending Direction